← Back to Search

Air Filtration

Air Purification for Cardiovascular Health in Seniors (RAPIDS2-Ypsi Trial)

N/A
Recruiting
Led By Robert Brook, MD
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
≥60 years old
Be older than 18 years old
Must not have
Cancer receiving active treatment or chemotherapy
Unable to provide informed consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks

Summary

This trial found that PM2.5 exposure is associated with an increased risk of CV events.

Who is the study for?
This trial is for seniors aged 60 or older living in Carpenter Place Apartments who don't smoke. Participants should not have had a cardiovascular event recently, be exposed to secondhand smoke daily, or have unstable heart conditions. They must also commit to not traveling overnight during the study and be on stable medication if they're being treated for high blood pressure, diabetes, or other heart issues.
What is being tested?
The study tests whether using an air purifier with a HEPA filter can reduce health problems related to fine particulate matter (PM2.5) pollution in seniors with cardiometabolic syndrome compared to a sham (fake) device.
What are the potential side effects?
Since this trial involves the use of an air purifier versus a sham device, there are no direct medical side effects expected from participating in this study.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 60 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am currently receiving treatment or chemotherapy for my cancer.
Select...
I am unable to understand and agree to the study's details on my own.
Select...
My blood pressure is not between 115 and 160/100 mm Hg.
Select...
I am on kidney dialysis.
Select...
I need oxygen therapy for my lung condition.
Select...
I have not had a heart attack, stroke, heart failure, or any heart surgery in the last 3 months.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Systolic Blood Pressure
Secondary study objectives
24-hr Blood Pressure
Aortic Hemodynamics
Atmospheric particulate matter (pm2.5)
+4 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: air filtration with hepa filterActive Control1 Intervention
air purifier used is the Holmes HAP8650B-NU-1 with the hepa filter inserted.
Group II: air filtration with hepa filter removedPlacebo Group1 Intervention
sham comparator uses the Holmes HAP8650B-NU-1 air purifier to be operated with the filter removed.

Find a Location

Who is running the clinical trial?

Michigan State UniversityOTHER
198 Previous Clinical Trials
685,700 Total Patients Enrolled
National Institute of Nursing Research (NINR)NIH
606 Previous Clinical Trials
10,378,661 Total Patients Enrolled
University of MichiganLead Sponsor
1,862 Previous Clinical Trials
6,441,412 Total Patients Enrolled
7 Trials studying Metabolic Syndrome
332 Patients Enrolled for Metabolic Syndrome
Robert Brook, MDPrincipal Investigator - Wayne State University
Rehabilitation Institute of Michigan
University Of Michigan Medical Sch (Medical School)
Northwestern University Medical Sch (Residency)
1 Previous Clinical Trials
50 Total Patients Enrolled

Media Library

Air Filtration with Air Purifier (Air Filtration) Clinical Trial Eligibility Overview. Trial Name: NCT04103346 — N/A
Metabolic Syndrome Research Study Groups: air filtration with hepa filter, air filtration with hepa filter removed
Metabolic Syndrome Clinical Trial 2023: Air Filtration with Air Purifier Highlights & Side Effects. Trial Name: NCT04103346 — N/A
Air Filtration with Air Purifier (Air Filtration) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04103346 — N/A
~0 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top